Previous close | 66.15 |
Open | 65.74 |
Bid | 65.38 x 350000 |
Ask | 65.61 x 350000 |
Day's range | 65.74 - 65.74 |
52-week range | 51.19 - 68.14 |
Volume | |
Avg. volume | 1 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 31 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
MetLife (MET) and GeoBlue launch Globaline, a comprehensive expatriate benefits solution, offering unified medical and ancillary coverage, leveraging extensive global health networks for seamless support.
NEW YORK, June 26, 2024--MetLife, Inc. (NYSE: MET) has published its 2023 Sustainability Report on how the company is living its purpose – Always with you, building a more confident future – through the strength of its people, products, services, and investments.
NEW YORK, June 25, 2024--MetLife and GeoBlue, the international solution for the Blue Cross® Blue Shield® companies, announced today they will offer a full suite of expatriate benefit products in a best-in-class single solution, Globaline™. Globaline™ brings together health coverage and services from GeoBlue – including medical, dental, vision, prescription, wellness, international employee assistance program and political and natural disaster assistance – and life, accidental death & dismemberm